This announcement is a separate document:
康寧傑瑞製藥-B：關連交易公告 - 與蘇州康寧傑瑞就JSKN003項目及KN062新冠抗體項目的技術開發合作
ALPHAMAB-B: CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU ALPHAMAB ON JSKN003 PROJECT AND KN062 COVID-19 ANTIBODY PROJECT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.